Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Yifan Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 23, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	15,752	13,040	18,014	15,019	21,745	23,372
Market Cap Growth	27.59%	-27.61%	19.94%	-30.93%	-6.96%	36.83%
Enterprise Value	17,147	14,371	19,400	16,499	22,717	23,710
Last Close Price	12.95	10.63	14.52	12.03	17.31	18.55
PE Ratio	35.92	33.78	-	78.54	78.11	24.14
Forward PE	25.39	20.82	33.59	16.33	32.78	16.68
PS Ratio	3.05	2.53	4.43	3.92	4.93	4.33
PB Ratio	1.82	1.55	2.18	1.64	2.48	2.68
P/TBV Ratio	3.68	3.29	4.67	2.82	4.23	4.70
P/FCF Ratio	96.59	1037.05	-	-	-	59.50
P/OCF Ratio	20.12	20.35	51.68	31.82	72.19	21.09
PEG Ratio	-	0.21	0.21	0.21	0.21	0.21
EV/Sales Ratio	3.32	2.79	4.77	4.30	5.15	4.39
EV/EBITDA Ratio	26.15	22.36	76.48	43.52	50.06	19.91
EV/EBIT Ratio	54.59	44.07	17820.38	96.29	86.48	23.38
EV/FCF Ratio	105.15	1142.95	-	-	-	60.36
Debt / Equity Ratio	0.27	0.27	0.24	0.24	0.26	0.19
Debt / EBITDA Ratio	3.50	3.49	7.34	5.44	4.84	1.39
Debt / FCF Ratio	14.08	182.47	-	-	-	4.23
Asset Turnover	0.42	0.43	0.34	0.31	0.37	0.48
Inventory Turnover	2.44	2.83	2.45	2.65	4.16	4.91
Quick Ratio	0.83	0.84	0.94	1.19	1.13	1.22
Current Ratio	1.31	1.26	1.49	1.68	1.56	1.65
Return on Equity (ROE)	4.62%	3.88%	-10.18%	1.42%	2.77%	11.25%
Return on Assets (ROA)	1.58%	1.71%	0.01%	0.87%	1.38%	5.58%
Return on Capital (ROIC)	1.82%	1.94%	0.01%	0.96%	1.53%	6.30%
Return on Capital Employed (ROCE)	3.30%	3.50%	0.00%	1.70%	2.70%	10.70%
Earnings Yield	2.77%	2.96%	-3.06%	1.27%	1.28%	4.14%
FCF Yield	1.04%	0.10%	-0.86%	-0.47%	-1.24%	1.68%
Dividend Yield	0.77%	1.88%	-	-	-	0.27%
Payout Ratio	27.74%	50.47%	-	45.18%	49.71%	20.86%
Buyback Yield / Dilution	1.09%	1.51%	3.94%	-5.32%	1.26%	-0.40%
Total Shareholder Return	1.85%	3.39%	3.94%	-5.32%	1.26%	-0.13%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.